Oncology and Hematology
Oncology and Hematology Clinical Practice
Stay current with Oncology and Hematology education that fits how you practice. ReachMD offers practical, on-demand clinical content for oncologists, hematologists, oncology nurses, pharmacists, fellows, APPs, and the full cancer care team. Explore expert discussions, case-based programs, CME/CE opportunities, industry features, and news across solid tumors, hematologic malignancies, biomarker-driven care, immunotherapy, targeted therapy, supportive care, and more.
Use this page to find relevant oncology and hematology content fast. Browse Project Oncology episodes, jump into CME/CE activities, review expert perspectives, or explore timely updates on evolving treatment strategies and standards of care. New content is added regularly, so you can stay current with emerging evidence, guideline updates, and multidisciplinary approaches to cancer care on your schedule.
Start with the latest programs below or browse by content type to find the Oncology and Hematology education most relevant to your practice.
121-135 of 362

Addressing Unmet Needs in Metastatic Uveal Melanoma
CME/CEAddressing Unmet Needs in Metastatic Uveal Melanoma

Patients First: Navigating Asparaginase-Based Treatment in Young Adults With ALL
CME/CEPatients First: Navigating Asparaginase-Based Treatment in Young Adults With ALL

The Safety Equation: Managing Adverse Events Associated With CSF1R Inhibitors in TGCT
MinuteCE®The Safety Equation: Managing Adverse Events Associated With CSF1R Inhibitors in TGCT

All Sides of the Joint: Integrated TGCT Care Across Specialties
MinuteCE®All Sides of the Joint: Integrated TGCT Care Across Specialties

Emerging Evidence in Focus: Interpreting Data on Next-Generation CSF1R TKIs
MinuteCE®Emerging Evidence in Focus: Interpreting Data on Next-Generation CSF1R TKIs
- advertisement

Beyond the Scalpel: When TGCT Surgery Isn’t the Solution
MinuteCE®Beyond the Scalpel: When TGCT Surgery Isn’t the Solution

Unlocking the CSF1R Code: Targeted Pathways and Tailored Choices
MinuteCE®Unlocking the CSF1R Code: Targeted Pathways and Tailored Choices

The Tumor That’s Not So Tiny: Understanding the Impact of TGCT
MinuteCE®The Tumor That’s Not So Tiny: Understanding the Impact of TGCT

Clinical Evidence in Focus: Interpreting Data on Systemic Therapy Targeting CSF1R
MinuteCE®Clinical Evidence in Focus: Interpreting Data on Systemic Therapy Targeting CSF1R

Applying the Evidence: TGCT Treatment Insights for Sports Medicine Physicians
MinuteCE®Applying the Evidence: TGCT Treatment Insights for Sports Medicine Physicians

Patient Perspective: Navigating TGCT Treatment—Surgery vs Systemic Therapy
MinuteCE®Patient Perspective: Navigating TGCT Treatment—Surgery vs Systemic Therapy
- advertisement

Surgical Crossroads: Practical Considerations for Optimizing Treatment in TGCT
MinuteCE®Surgical Crossroads: Practical Considerations for Optimizing Treatment in TGCT

Unmet Needs in Endocrine Therapy: Rethinking the HR+/HER2- mBC Treatment Roadmap
MinuteCE®Unmet Needs in Endocrine Therapy: Rethinking the HR+/HER2- mBC Treatment Roadmap

Safety of CDK4/6 Inhibitors: Anticipation, Prevention, and Management of Adverse Events
MinuteCE®Safety of CDK4/6 Inhibitors: Anticipation, Prevention, and Management of Adverse Events


































